000 | 02214 a2200637 4500 | ||
---|---|---|---|
005 | 20250517050526.0 | ||
264 | 0 | _c20151208 | |
008 | 201512s 0 0 eng d | ||
022 | _a1546-170X | ||
024 | 7 |
_a10.1038/nm.3930 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHrustanovic, Gorjan | |
245 | 0 | 0 |
_aRAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer. _h[electronic resource] |
260 |
_bNature medicine _cSep 2015 |
||
300 |
_a1038-47 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnaplastic Lymphoma Kinase |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 |
_aDual Specificity Phosphatase 6 _xphysiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aMitogen-Activated Protein Kinase Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aMitogen-Activated Protein Kinases _xphysiology |
650 | 0 | 4 |
_aOncogene Proteins, Fusion _xanalysis |
650 | 0 | 4 |
_aProto-Oncogene Proteins _xgenetics |
650 | 0 | 4 | _aProto-Oncogene Proteins p21(ras) |
650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aras Proteins _xgenetics |
700 | 1 | _aOlivas, Victor | |
700 | 1 | _aPazarentzos, Evangelos | |
700 | 1 | _aTulpule, Asmin | |
700 | 1 | _aAsthana, Saurabh | |
700 | 1 | _aBlakely, Collin M | |
700 | 1 | _aOkimoto, Ross A | |
700 | 1 | _aLin, Luping | |
700 | 1 | _aNeel, Dana S | |
700 | 1 | _aSabnis, Amit | |
700 | 1 | _aFlanagan, Jennifer | |
700 | 1 | _aChan, Elton | |
700 | 1 | _aVarella-Garcia, Marileila | |
700 | 1 | _aAisner, Dara L | |
700 | 1 | _aVaishnavi, Aria | |
700 | 1 | _aOu, Sai-Hong I | |
700 | 1 | _aCollisson, Eric A | |
700 | 1 | _aIchihara, Eiki | |
700 | 1 | _aMack, Philip C | |
700 | 1 | _aLovly, Christine M | |
700 | 1 | _aKarachaliou, Niki | |
700 | 1 | _aRosell, Rafael | |
700 | 1 | _aRiess, Jonathan W | |
700 | 1 | _aDoebele, Robert C | |
700 | 1 | _aBivona, Trever G | |
773 | 0 |
_tNature medicine _gvol. 21 _gno. 9 _gp. 1038-47 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/nm.3930 _zAvailable from publisher's website |
999 |
_c25196486 _d25196486 |